Alzheimer Disease Clinical Trial
— TACADOfficial title:
To Reduce the Burden of Caregiving on Health Outcomes of Midlife Women: Asian American Family Caregivers of Persons Living With Alzheimer's Disease
The purpose of the proposed study is to preliminarily evaluate Technology-based information and coaching/support program that is tailored for Asian American midlife women who are family caregivers of patients living with Alzheimer's disease (TACAD) in improving health outcomes of Asian American midlife women who are family caregivers of persons living with Alzheimer's disease (AACA) and their care recipients.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | August 31, 2024 |
Est. primary completion date | August 31, 2024 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 40 Years to 65 Years |
Eligibility | Inclusion Criteria: - self reported AACA. - Participants will be included if, by self-report, they are Asian American women aged 40 to 65 years old who identify as Chinese or Korean; - are family caregivers of PLAD; - can read and write English, Mandarin Chinese or Korean; - who reside in the U.S.; - have access to the Internet through computers or mobile devices. - Participants must be providing at least 4 hours per day unpaid assistance, on average, for a community-dwelling person in the early-middle stage of illness (Clinical Dementia Rating of 1) for whom there is no plan for institutionalization in six months. - Caregivers may or may not reside with their care recipient. Exclusion Criteria: - Those who used the AA website previously and/or participated in other studies related to AD will be excluded. |
Country | Name | City | State |
---|---|---|---|
United States | The University of Texas at Austin | Austin | Texas |
United States | University of Texas at Austin | Austin | Texas |
Lead Sponsor | Collaborator |
---|---|
University of Texas at Austin |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Multidimensional Caregiver Strain Index from baseline | Is a questionnaire that evaluates caregiver's health outcome. Total possible score range is 0-26. Higher score correlates with worse outcome. | Baseline, 1 months post intervention, 3 months post intervention | |
Primary | Change in Perceived Stress Scale score from baseline | Measure of individual stress. Possible score range is 0-40 with higher scores indicating higher perceived stress. | Baseline, 1 months post intervention, 3 months post intervention | |
Primary | Change in Acculturation Stress Scale (ASS) score from baseline | Score range is 0-36. Higher score correlates with worse outcome (higher stress) | Baseline, 1 months post intervention, 3 months post intervention | |
Primary | Change in Social Readjustment Rating Scale (SRRS) score from baseline | This questionnaire asks about number the of events in the last 12 months. Total score range 0-41 and higher score correlates with higher stress. | Baseline, 1 months post intervention, 3 months post intervention | |
Primary | Change in Midlife Women's Symptom Index from baseline | This questionnaire measures physical and psychological symptoms during the last 6 months. It includes 73 questions that can be rated from 0-4. Possible score ranges from 0-292. Higher score correlates with worse outcome. | Baseline, 1 months post intervention, 3 months post intervention | |
Primary | Change in EQ-5D-5L scale score from baseline | This is a generic health status measure by the EuroQol Group to measure quality of daily life. It includes five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/ depression) with five responses for each dimension (no problem to extreme problems); each digit in the five-digit codes refers to the status of each dimension, ranging from 1 (no problem) to 5 (severe problem). Possible score ranges from 0 to 100. A higher score in the EQ-5D-5L indicated better health-related Quality of Life. | Baseline, 1 months post intervention, 3 months post intervention | |
Primary | Change in Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) score from baseline | This questionnaire measures the cognitive status of care recipients. Total possible score ranges from 8-40. Higher score correlates with worse outcome. | Baseline, 1 months post intervention, 3 months post intervention | |
Primary | Change in Lawton ADL/IADL Scale score from baseline | This questionnaires measures instrumental activities of daily living. The Lawton IADL scale contains eight items, with a summary score from 0 (low function) to 8 (high function). Possible total score ranges from 0 (low function, dependent) to 8 (high function, independent) for women, and 0 through 5 for men. The higher the score, the greater the person's abilities. | Baseline, 1 months post intervention, 3 months post intervention | |
Primary | Change in Revised Memory and Behavior Problem Checklist score from baseline | This outcome measures behavioral and psychological symptoms of care recipients. Total possible score ranges between 0-96 with higher score correlating with worse outcome. | Baseline, 1 months post intervention, 3 months post intervention | |
Primary | Change in Neuropsychological Inventory Questionnaire score from baseline | This questionnaire measures care recipients' mood status. This is a 12-item inventory assessing severity of mood states or behaviors reflecting mood. The severity scale has scores ranging from 1 to 3 points (1=mild; 2=moderate; and 3=severe) and the scale for assessing caregiver distress has scores ranging from 0 to 5 points (0=no distress; 1=minimal distress; 2=mild distress; 3=moderate distress; 4=severe distress; and 5=extreme distress). Total possible score ranges 0 to 144. | Baseline, 1 months post intervention, 3 months post intervention | |
Primary | Change in Quality of Life Scale in Alzheimer's Disease score from baseline | This questionnaire assesses quality of life (QOL) in 13 domains on a one 4-point Likert scale. It is used as a self-report and surrogate-report instrument. It uses a scale of 1-4 (poor, fair, good, or excellent) to rate a variety of life domains, including the patient's physical health, mood, relationships, activities, and ability to complete tasks. Total possible score ranges 13 to 52. | Baseline, 1 months post intervention, 3 months post intervention | |
Secondary | Change in Caregiver Activity Survey score from baseline | This survey measures the time caregivers spend aiding Alzheimer's patients with their day-to-day activities. The instrument includes 6 areas of caregiving activities (communicating with the person, using transportation, dressing, eating, looking after one's appearance, and supervising the person). Each items score reflects how many minutes is spent in that activity during the day prior to each assessment, and total scores are calculated in hours. Total possible score ranges from 0 to 24 hours. Higher scores indicate greater caregiver distress. | Baseline, 1 months post intervention, 3 months post intervention | |
Secondary | Change in Ways of Coping Scale score from baseline | This scale measures caregivers' coping status. It is a 42-item scale with 4-point Likert responses that identifies emotion- and problem-focused coping responses of caregivers. Possible score range is 0-198. Higher score correlates with better outcome. | Baseline, 1 months post intervention, 3 months post intervention | |
Secondary | Change in Pearlin Mastery, Loss, and Competence Scale score from baseline | This scale measures the extent to which an individual regards their life chances as being under their personal control rather than fatalistically ruled. Individual items use a 4-point Likert scale (1,"Strongly disagree" and 4,"Strongly agree"). Possible total score ranges 7 to 28. Higher scores indicate greater levels of mastery. | Baseline, 1 months post intervention, 3 months post intervention | |
Secondary | Change in Caregiver Assessment of Behavioral Skill Scale score from baseline | This scale measures caregiving skills. This is a 17-item self-report assessment of behavioral management skills. Each item is measured on a 3-point Likert scale (0 = "seldom true" to 2 = "true most of the time"). Possible total score ranges from 0-34. Higher scores indicates greater behavioral skill. | Baseline, 1 months post intervention, 3 months post intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |